Jorn Aldag

Jorn Aldag is a declared insider of HOOKIPA Pharma Inc. (chief executive), with filings sourced from SEC (Form 4). In total, 5 filings cover trades dated from 1 February 2022 to 11 July 2023.

Purchases make up the whole of the open-market record (4 purchases, €16k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant. So far in 2023, the count stands at 4 purchases and no sales.

Half of the purchases are above €3,922 and half below. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 11 July 2023: an open-market purchase of €3,719, in HOOKIPA Pharma Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.